https://the483.com/astrazeneca-tozorakimab-third-phase3-win/ The 483 en 2026-04-20T17:27:18.000Z Wins Third Phase 3 in COPD: AstraZeneca's Tozorakimab Eyes $5B Peak https://the483.com/lilly-kelonia-vivo-car-t-deal/ The 483 en 2026-04-20T16:31:25.000Z Lilly Bets on Kelonia's In Vivo CAR-T https://the483.com/novo-etavopivat-scd-fda-filing/ The 483 en 2026-04-20T13:51:19.530Z Novo Targets FDA Filing for Etavopivat After 27% VOC Reduction https://the483.com/kailera-625m-record-biotech-ipo/ The 483 en 2026-04-19T00:45:09.000Z Kailera Raises $625M in Record Biotech IPO on Nasdaq https://the483.com/federal-savings-bank-occ-va-deception/ The 483 en 2026-04-18T23:14:45.000Z OCC Hits Federal Savings Bank With Consent Order for Deceptive VA Loan Ads https://the483.com/fincen-whistleblower-award-nprm/ The 483 en 2026-04-18T22:12:22.000Z FinCEN Filed NPRM Offering 10-30% Cut to Financial Crime Whistleblowers https://the483.com/kraken-bitnomial-550m-cftc-derivatives/ The 483 en 2026-04-18T21:32:09.236Z Kraken Paid $550M for Bitnomial's Triple CFTC License Stack